首页> 美国卫生研究院文献>Pharmaceutics >Oleic Acid Copolymer as A Novel Upconversion Nanomaterial to Make Doxorubicin-Loaded Nanomicelles with Dual Responsiveness to pH and NIR
【2h】

Oleic Acid Copolymer as A Novel Upconversion Nanomaterial to Make Doxorubicin-Loaded Nanomicelles with Dual Responsiveness to pH and NIR

机译:油酸共聚物作为一种新型上转换纳米材料使载入的纳米型纳米成分与pH和NIR的双重反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oleic acid (OA) as main component of plant oil is an important solvent but seldom used in the nanocarrier of anticancer drugs because of strong hydrophobicity and little drug release. In order to develop a new type of OA nanomaterial with dual responses to pH and near infrared light (NIR) to achieve the intelligent delivery of anticancer drugs. The novel OA copolymer (mPEG-PEI-(NBS, OA)) was synthesized by grafting OA and -nitrobenzyl succinate (NBS) onto mPEGylated polyethyleneimine (mPEG-PEI) by amidation reaction. It was further conjugated with NaYF :Yb /Er nanoparticles, and encapsulated doxorubicin (DOX) through self-assembly to make upconversion nanomicelles with dual response to pH and NIR. Drug release behavior of DOX, physicochemical characteristics of the nanomicelles were evaluated, along with its cytotoxic profile, as well as the degree of cellular uptake in A549 cells. The encapsulation efficiency and drug loading capacity of DOX in the nanomicelles were 73.84% ± 0.58% and 4.62% ± 0.28%, respectively, and the encapsulated DOX was quickly released in an acidic environment exposed to irradiation at 980 nm. The blank nanomicelles exhibited low cytotoxicity and excellent biocompatibility by MTT assay against A549 cells. The DOX-loaded nanomicelles showed remarkable cytotoxicity to A549 cells under NIR, and promoted the cellular uptake of DOX into the cytoplasm and nucleus of cancer cells. OA copolymer can effectively deliver DOX to cancer cells and achieve tumor targeting through a dual response to pH and NIR.
机译:油酸(OA)作为植物油的主要成分是一种重要的溶剂,但由于强烈的疏水性和少量药物释放,抗癌药物的纳米载体很少。为了开发一种具有双重反应的新型OA纳米材料,对pH和近红外光(NIR)进行了双重反应,以实现抗癌药物的智能交付。通过酰胺化反应将OA和 - 硝基苄基琥珀酸盐(NBS)嫁接到MPEG化的聚乙烯(MPEG-PEI)上,合成新型OA共聚物(MPEG-PEI-(NBS,OA))。它通过自组装与Nayf:Yb / ER纳米颗粒和封装的多柔比星(DOX)缀合,以使高载纳米与pH和NIR进行双重反应。对DOX的药物释放行为,评价纳米素的物理化学特性,以及其细胞毒性剖面以及A549细胞中的细胞摄取程度。在纳米内部的DOX的封装效率和药物负载能力分别为73.84%±0.58%和4.62%±0.28%,并且在暴露于980nm的耐辐射的酸性环境中快速释放包封的DOX。空白的纳米乳蛋白表现出低细胞毒性和通过MTT测定对A549细胞的优异的生物相容性。 Dox加载的纳米乳蛋白显示出在NIR下的A549细胞上显着的细胞毒性,并促进了DOX的细胞吸收到癌细胞的细胞质和核。 OA共聚物可以有效地将DOX递送给癌细胞,并通过对pH和NIR的双重反应来实现肿瘤靶向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号